10:00 – 10:45 | Prof. Yitshak Kreiss, Director General, Sheba Medical Center
10:45 – 11:15 | Philippe Gallone, Partner and Head of Healthcare Investment Banking in EMEA, Goldman Sachs
11:15 – 11:45 | Prof. Yinon Ben Neriah, The Faculty of Medicine, Hebrew University of Jerusalem, Awarded 2025 the Israel Prize in the Field of Medical Research, “Why Cancer still Outsmarts Us: Challenges in the development of Cancer Therapeutics”
HALL A
War-Time Innovation, Peace-Time Solutions
Moderator:
Avner Halperin, CEO, Sheba Impact
HALL B
Rewiring the Brain: Breakthroughs in Neurotech and Neuromodulation,
Moderators:
Barry Greene, CEO, Sage Therapeutics
Iris Grossman, PhD, Chief Therapeutics Officer, Eleven Therapeutics
HALL C
AI Meets Pharma:Building a Sustainable Value for Biotech AI Innovation in Drug Development
Moderators:
Karin Noy, PhD, Senior Director, Pfizer
Yanay Ofran, PhD, Founder and Chairman, Biolojic Design
HALL A
Aging Redefined: Breakthroughs in Science and Technology in Longevity
10:00 – 10:20 | Dror Bin, Chief Executive Officer, Israel Innovation Authority
Bankers and VC Panel: “The Investment Tango: VCs, Bankers, and the Dance of Deal-Making”
Bankers:
Michael Margolis, Senior Managing Director, Head of Healthcare Investment Banking, Oppenheimer & Co.
Michael Rice, Founding Partner, LifeSci Advisors
Venture Capital:
Nick Pachuda, MD, General Partner, Neovate Capital Partners
Mitchell Gold, MD, Venture Partner, Frazier Life Sciences; Alpine Immune Sciences, Ex-CEO
Ittai Harel, Managing Partner, Pitango Venture Capital
Jing Bao, MD, PhD., Partner, Shanghai Healthcare Capital (SHC)
Craig Yeshion, MD, Managing Director, Specialty Pharmaceuticals & Medical Devices, Perceptive Advisors
Boaz Hirshberg, MD, Senior Vice President, Clinical Development Unit Head, Internal Medicine, Regeneron, “Regeneron: Relentless Innovation Powering an Impactful Pipeline from Allergy to Obesity and Beyond”
HALL A
(I&I) Immunology and Inflammation Reclaim top Priorities in BioPharma: Driver and Opportunities?
Moderators:
Iris Grossman, PhD., Chief Therapeutics Officer, Eleven Therapeutics
Prof. Amnon Peled, MD., Hadassah Medical Center
HALL B
HALL A
Illuminating the Path: Innovations and Challenges in Eye Care
Moderators:
Anat Loewenstein, MD., President of the Israeli Ophthalmological Society, Dean of the Faculty of Medicine, Tel Aviv University, Chairperson of Ophthalmology, Sourasky Medical Center
Barak Azmon, MD., Entrepreneur
Jonathan Weyne, MD., Vice President Ophthalmology Therapeutic, Regeneron
HALL B
AI’s Next Leap in HealthTech – From Buzzwords (Gen AI, Agentic, LLM and Foundation Models) to Real World examples
Moderator:
Avi Veidman, CEO, Nucleai
10:00 – 10:30 | Rony Paz; Dean, Faculty of Biology; Director, Azrieli Institute for Brain and Neural Sciences; Weizmann Institute of Science
10:30 – 11:00 | Nick Pachuda, MD., General Partner, Neovate Capital Markets
HALL A
Evolving Trends in Orthopedic Innovations
Moderator:
Yuval Mandelbaum, CEO, Discure Technologies
HALL B
HALL A
Defining the future – BioMed Start-ups Showcase and Competition
Moderators:
Yael Gruenbaum -Cohen, DMD, Ph.D., Partner & Head, aMoon Alpha
Adar Makovski – Silverstein, VC, Business Development, Arkin Bio Ventures
